Making the Call in Nonadvanced Systemic Mastocytosis: Optimizing Multidisciplinary Management
This series is provided by Global Education Group. (ACCME Credit).
This series is jointly provided by Global Education Group and Integritas Communications. (AANP Credit).
This series is supported by an independent educational grant from Blueprint Medicines Corporation.
Program Overview
Nonadvanced systemic mastocytosis (SM) is a group of rare disorders characterized by mast cell accumulation that results in a significant and varied symptomatic burden to the patient. The most prevalent of these symptoms include gastrointestinal symptoms, dermatological symptoms, and recurrent anaphylaxis in response to a variety of triggers such as food, insect venom, and medications. In this Phone-a-Friend series, a multidisciplinary panel of faculty experts will address the importance of high-sensitivity assays to detect the KIT D816V mutation that is responsible for most cases of nonadvanced SM, the recently updated World Health Organization diagnostic criteria, the various triggers of mast cell activation, symptom assessment techniques, and patient education. The faculty will also discuss individualization of symptom-directed treatment strategies, evolving treatment options, and newly approved targeted therapies for the treatment of nonadvanced SM.
Target Audience
The educational design of this activity addresses the needs of allergy/clinical immunology, gastroenterology, dermatology, and hematology clinicians who manage patients with nonadvanced SM.
Modules
Identifying and Assessing Burdens in Nonadvanced Systemic Mastocytosis
Faculty Tracy I. George, MD; Matthew P. Giannetti, MD
Credits Maximum of 0.25 AMA PRA Category 1 Credit™ and 0.25 AANP contact hour(s)
Expiration2024-06-05
Diagnosis and Management of Patients With Predominant Skin Symptoms
Faculty Anthony P. Fernandez, MD, PhD; Matthew P. Giannetti, MD
Credits Maximum of 0.25 AMA PRA Category 1 Credit™ and 0.25 AANP contact hour(s)
Expiration2024-06-21
Diagnosis and Management of Patients With Predominant Gastrointestinal Symptoms
Faculty Matthew P. Giannetti, MD; Matthew J. Hamilton, MD
Credits Maximum of 0.25 AMA PRA Category 1 Credit™ and 0.25 AANP contact hour(s)
Expiration2024-07-14